Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the Class A common stock, par value $0.01 per share, of Evolent Health, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: August 20, 2020
| | Engaged Capital Flagship Master Fund, LP |
| | |
| | By: | Engaged Capital, LLC
General Partner |
| | |
| | By: | /s/ Glenn W. Welling |
| | | Name: | Glenn W. Welling |
| | | Title: | Founder and Chief Investment Officer |
| | Engaged Capital Co-Invest XI, LP |
| | |
| | By: | Engaged Capital, LLC
General Partner |
| | |
| | By: | /s/ Glenn W. Welling |
| | | Name: | Glenn W. Welling |
| | | Title: | Founder and Chief Investment Officer |
| | Engaged Capital Special Situation Fund, LP |
| | |
| | By: | Engaged Capital, LLC
General Partner |
| | |
| | By: | /s/ Glenn W. Welling |
| | | Name: | Glenn W. Welling |
| | | Title: | Founder and Chief Investment Officer |
| | Engaged Capital Flagship Fund, LP |
| | | |
| | By: | Engaged Capital, LLC
General Partner |
| | |
| | By: | /s/ Glenn W. Welling |
| | | Name: | Glenn W. Welling |
| | | Title: | Founder and Chief Investment Officer |
| | Engaged Capital Flagship Fund, Ltd. |
| | | |
| | By: | /s/ Glenn W. Welling |
| | | Name: | Glenn W. Welling |
| | | Title: | Director |
| | Engaged Capital, LLC |
| | |
| | By: | /s/ Glenn W. Welling |
| | | Name: | Glenn W. Welling |
| | | Title: | Founder and Chief Investment Officer |
| | Engaged Capital Holdings, LLC |
| | |
| | By: | /s/ Glenn W. Welling |
| | | Name: | Glenn W. Welling |
| | | Title: | Sole Member |
| | /s/ Glenn W. Welling |
| | Glenn W. Welling |
